-
Pharma CEO: Trust Me, Price-Gouging The Sick Is The Best Way To Help Them
Turing Pharma CEO Martin Shkreli has decided he will NOT drop the price of Daraprim.
-
New York Launches Investigation Into Martin Shkreli's AIDS Drug Price-Gouging
Martin Shkreli, the CEO who jacked up the price of an AIDS drug by 5000%, is now under investigation by the NY Attorney General’s office.